OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences

OTR Acquisition Corp. (NASDAQ:OTRAU, OTRA and OTRAW))), a publicly traded special purpose acquisition company (SPAC), today announced the confidential submission with the U.S. Securities and Exchange Commission (“SEC”) of a draft registration statement on Form S-4 (the “Registration Statement”) relating to its previously announced proposed business combination with Comera Life Sciences, Inc.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220203006027/en/

In addition, the investor call with Comera and OTR has been rescheduled to Tuesday, Feb. 8 at 8:30 a.m. EST (from previous date and time of Friday, Feb. 4 at 8:30 a.m. EST) to discuss the proposed business combination. An audio webcast of the event will be available on the OTR Investor Relations website at https://otracquisition.com/investors/.